Seasoned Leader Jim Kean Takes the Helm as CEO of Molecular You for US Expansion
July 18, 2023 09:34 ET
|
Molecular You Corporation
VANCOUVER, British Columbia, July 18, 2023 (GLOBE NEWSWIRE) -- Molecular You is thrilled to announce the appointment of Jim Kean as CEO to spearhead the company's expansion efforts in the United...
Molecular You launches a new preventive solution shown to improve health outcomes over 100 days
January 10, 2023 08:38 ET
|
Molecular You Corporation
VANCOUVER, British Columbia, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Molecular You announced the launch of its preventive digital health solution, based on a new type of blood test that leverages their...
Fountain Health Announces Full Coverage on Neurological Imaging
November 15, 2022 09:00 ET
|
Fountain Health Insurance
NAPLES, Fla., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Fountain Health is proud to officially announce 100 percent coverage of Combinostics cMRI™ and cDSI™ — the industry-leading AI-enabled neurological...
GoodCell Adds HSA Bank to its Network, Expanding the Company’s Targeted Reach to HSA & FSA Account Holders
November 02, 2022 07:30 ET
|
GoodCell
Norwalk, CT, Nov. 02, 2022 (GLOBE NEWSWIRE) -- GoodCell, a life sciences company, added HSA Bank, a division of Webster Bank, N.A., to its growing network comprised of benefits administrators,...
GoodCell Launches in Concierge Practices to Meet the Demand for Proactive & Preventative Longevity Services
October 20, 2022 07:30 ET
|
GoodCell
Atlanta, GA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- At Concierge Medicine Today’s annual Forum, GoodCell, a life sciences company, launched its Personal Biobanking service in concierge medicine practices...
GoodCell Launches “On-The-Go” Delivering Turnkey, Onsite Onboarding for 2022 Open Enrollment Season
October 03, 2022 07:30 ET
|
GoodCell
Norwalk, CT, Oct. 03, 2022 (GLOBE NEWSWIRE) -- GoodCell, a medically-actionable service to identify, track and manage chronic diseases and conditions impacting millions of Americans, today launched...
Life Line Screening accelerates its clinical research transformation by appointing Matthew Maxwell as Chief of Clinical Research Strategy.
January 29, 2021 07:00 ET
|
Life Line Screening
Mr. Maxwell will be responsible for unlocking Life Line Screening’s distinctive ability to connect motivated patients to compelling clinical research opportunities. AUSTIN, Texas, Jan. 29, 2021 ...
PreveCeutical™ Medical Inc. Announces Preliminary Results from Phase One of its Venom Re-Engineering Project
August 11, 2017 03:05 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 11, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces encouraging results from the Research and...
PreveCeutical™ Medical Inc. Signs Letter of Intent with UniQuest Pty Limited for Research & Development Program Engineering Peptide Therapeutics for Non-Addictive Analgesics
August 08, 2017 03:05 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 08, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces that on August 7, 2017, the Company signed...
PreveCeutical™ Medical Inc. Begins Trading on the Frankfurt Stock Exchange
August 01, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the listing of its common shares for trading on the...